Matthew E. Griffin
Impact in
-
- Glycosylation and Glycoproteins Research
- Gut microbiota and health
Papers in
-
- Glycosylation and Glycoproteins Research 9
- Gut microbiota and health 3
-
- Proteoglycans and glycosaminoglycans research 7
- Co-authors
- Linda C. Hsieh‐Wilson (10 shared papers)Howard C. Hang (3 shared papers)Juliel Espinosa (2 shared papers)Abigail Pulsipher (3 shared papers)Ji‐Dung Luo (1 shared paper)Jyoti K. Jha (1 shared paper)Thomas S. Carroll (1 shared paper)Gary R. Fanger (1 shared paper)
- Journals
- Nature Chemical Biology (3 papers)ACS Chemical Biology (2 papers)Cell chemical biology (2 papers)Current Opinion in Chemical Biology (2 papers)Clinical & Translational Immunology (1 paper)
- Partner nations
- United StatesArgentinaSouth Korea
In The Last Decade
Matthew E. Griffin
19 papers receiving 844 citations
Matthew E. Griffin's Hit Papers
Peers
Comparison fields: 5 of 90
- Molecular Biology 586
- Biological Psychiatry 19
- Biotechnology 67
- Immunology 148
- Cell Biology 110
Countries citing papers authored by Matthew E. Griffin
This map shows the geographic impact of Matthew E. Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Griffin more than expected).
Fields of papers citing papers by Matthew E. Griffin
This network shows the impact of papers produced by Matthew E. Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Griffin. The network helps show where Matthew E. Griffin may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew E. Griffin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy Hit paper breakdown → | 2021 | 249 |
| 2 | 2014 | 74 | |
| 3 | 2014 | 61 | |
| 4 | 2016 | 61 | |
| 5 | 2022 | 53 | |
| 6 | 2017 | 52 | |
| 7 | 2016 | 44 | |
| 8 | 2020 | 44 | |
| 9 | 2019 | 32 | |
| 10 | 2019 | 31 | |
| 11 | 2020 | 28 | |
| 12 | 2023 | 27 | |
| 13 | 2013 | 25 | |
| 14 | 2022 | 23 | |
| 15 | 2021 | 14 | |
| 16 | 2010 | 12 | |
| 17 | 2022 | 12 | |
| 18 | 2023 | 7 | |
| 19 | 2014 | 6 | |
| 20 | 2024 | 0 |
About Matthew E. Griffin
Matthew E. Griffin is a scholar working on Molecular Biology, Cell Biology, Organic Chemistry, Immunology and Oncology, having authored 21 papers that have together received 855 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (9 papers), Proteoglycans and glycosaminoglycans research (7 papers), Carbohydrate Chemistry and Synthesis (5 papers), Gut microbiota and health (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Tryptophan and brain disorders (2 papers). The work is most often cited by research in Molecular Biology (586 citations), Biological Psychiatry (19 citations), Biotechnology (67 citations), Immunology (148 citations) and Cell Biology (110 citations). Matthew E. Griffin has collaborated with scholars based in United States, Argentina and South Korea. Frequent co-authors include Linda C. Hsieh‐Wilson, Howard C. Hang, Juliel Espinosa, Abigail Pulsipher, Ji‐Dung Luo, Jyoti K. Jha, Thomas S. Carroll, Gary R. Fanger, Howard C. Hang and John W. Thompson. Their work appears in journals such as Nature Chemical Biology, ACS Chemical Biology, Cell chemical biology, Current Opinion in Chemical Biology and Clinical & Translational Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.